# US 2025/0051743 A1 · Materials and methods for increasing gene editing frequency

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0051743 A1
- Document ID: US20250051743A1
- Status: Published application
- Kind: A1
- Application number: 18/815,218
- Filed: 2024-08-26
- Published: 2025-02-13
- Earliest claimed: 2017-06-13
- Assignees: Regents of the University of Minnesota
- Applicants: Regents of the University of Minnesota
- Inventors: Wendy R. Gordon; Eric Aird; Klaus Lovendahl
- Web page: https://patentgrep.com/patent/US20250051743A1

## CPC

- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Materials and methods for gene editing using improved targeted endonucleases and endonuclease systems (e.g., Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) endonuclease systems) are provided herein.

## Claims

### Claim at position 1

1-19. (canceled)

### Claim 20

A fusion polypeptide comprising (a) an endonuclease polypeptide and (b) an HUH tag.

### Claim 21 (depends on 20)

The fusion polypeptide of claim 20, further comprising a linker between said endonuclease polypeptide and said HUH tag.

### Claim 22 (depends on 20)

The fusion polypeptide of claim 20, wherein said HUH tag is fused at the N-terminus of said endonuclease polypeptide.

### Claim 23 (depends on 20)

The fusion polypeptide of claim 20, wherein said HUH tag is fused to the C-terminus of said endonuclease polypeptide.

### Claim 24 (depends on 20)

The fusion polypeptide of claim 20, wherein said endonuclease polypeptide is a zinc finger nuclease.

### Claim 25 (depends on 20)

The fusion polypeptide of claim 20, wherein said endonuclease polypeptide is a meganuclease.

### Claim 26 (depends on 20)

The fusion polypeptide of claim 20, wherein said endonuclease polypeptide is a Cas9 endonuclease.

### Claim 27 (depends on 26)

The fusion polypeptide of claim 26, wherein said endonuclease polypeptide comprises one or more mutations as compared to a Cas9 endonuclease having the amino acid sequence set forth in SEQ ID NO:14 or SEQ ID NO:15.

### Claim 28 (depends on 27)

The fusion polypeptide of claim 27, wherein said one or more mutations reduce the endonuclease activity of said Cas9 endonuclease, reduce non-specific activity of said Cas9 endonuclease, or cause said Cas9 endonuclease to have nickase activity rather than double strand cleavage activity.

### Claim 29 (depends on 26)

The fusion polypeptide of claim 26, wherein said fusion polypeptide comprises a DNA containing a single-stranded sequence, wherein said single-stranded sequence is covalently attached to said HU H tag.

### Claim 30 (depends on 20)

The fusion polypeptide of claim 20, wherein said HUH tag comprises the amino acid sequence set forth in SEQ ID NO:1.
